Back

Real World Data: Improvement of echocardiographic parameters, response and quality of life to Cardiac Resynchronization Therapy (CRT) continues up to 12 months after implantation

18 March 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - CRT Cardiac Resynchronization Therapy EHRA Premium Access EHRA 2018

About the speaker

Photo
Associate Professor Fabian Schiedat

Marienhospital, Gelsenkirchen (Germany)

19 More presentations in this session

Presentation thumbnail
Baseline characteristics and outcome of the resynchronization therapy in patients with valvular heart disease: single-center experience.
Doctor T. Boumedien (Algiers, DZ)
Abstract
Presentation thumbnail
Sleep apnea detection by a cardiac resynchronization device integrated thoracic impedance sensor - a validation study against the gold standard polysomnography
Doctor F. Barbieri (Berlin, DE)
Abstract
Presentation thumbnail
A super outcome to a super response
Doctor V. Marinho (Coimbra, PT)
Abstract Slides
Presentation thumbnail
Non-invasively assessed coronary flow reserve predicts survival in patients treated with cardiac resynchronization therapy
Doctor V. Jovanovic (Belgrade, RS)
Abstract
Presentation thumbnail
Mechanical dyssynchrony as a predictor of superresponse in patients with cardiac resynchronisation therapy
Mr N. Shirokov (Tyumen, RU)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - CRT

The Event

Event poster

EHRA 2018

18 March - 20 March 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources